Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Duggan Insider Profile
32 Followers
Robert Duggan, Chairman & CEO, Director, Ten Percent Owner at Pharmacyclics, holds 551.70M shares in Summit Therapeutics (Ticker: SMMT), holds 43.13M shares in Pulse Biosciences (Ticker: PLSE), holds 5.76M shares in Achaogen (Ticker: AKAOQ).
Robert Duggan Pharmacyclics (PCYC)Chairman & CEO, Director, Ten Percent Owner
Pharmacyclics (PCYC)
Chairman & CEO, Director, Ten Percent Owner
Ranked #81,645 out of 99,635 Corporate Insiders
Profitable Transactions
20 out of 54 Profitable Transactions
Average Return
-6.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Duggan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 08, 2023 - Mar 08, 2024
Return:+189.40%
The most profitable trade made by Robert Duggan
Robert Duggan's Trading History
Pharmacyclics
May 27, 2015
―
Uninformative Sell
3.55B
―
Pulse Biosciences
Dec 14, 2023
Director, Ten Percent Owner
Informative Buy
164.69K
$775.76M
Achaogen
Mar 20, 2019
―
Informative Sell
685.44K
$143.95K
Summit Therapeutics
Sep 13, 2024
Co- CEO, Director, Ten Percent Owner
Uninformative Buy
75.50M
$10.59B
Intuitive Surgical
May 18, 2011
Director
Informative Buy
47.09K
$536.55K
List of latest transactions for each holding click on a transaction to see Robert Duggan's performance on stock
You May Also Like
Robert Duggan insider profile FAQ
What is the percentage of profitable transactions made by Robert Duggan?
The percentage of profitable transactions made by Robert Duggan is 37%.
What is the average return per transaction made by Robert Duggan?
The average return per transaction made by Robert Duggan is -6.50%.
What stocks does Robert Duggan hold?
Robert Duggan holds: PCYC, PLSE, AKAOQ, SMMT, ISRG stocks.
What was Robert Duggan’s latest transaction?
Robert Duggan latest transaction was an Uninformative Buy of $75.50M.
What was Robert Duggan's most profitable transaction?
Robert Duggan’s most profitable transaction was an Informative Buy of SMMT stock on March 8, 2023. The return on the trade was 189.40%.
What is Robert Duggan's role in Pharmacyclics?
Robert Duggan's role in Pharmacyclics is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.